A Research Study to Evaluate MK0653 (Ezetimibe) and Simvastatin, Given Together and Alone, on Intestinal Absorption of Cholesterol (0653-050)(COMPLETED)

Status:
Completed

Trial end date:
2004-04-01

Target enrollment:

Participant gender:

To determine the effect of ezetimibe and simvastatin given together, and ezetimibe and simvastatin given alone on intestinal cholesterol absorption.

Phase 3

Merck Sharp & Dohme Corp.

Schering-Plough

Ezetimibe
Simvastatin